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tion remains controversial. However, further
efforts to standardise new commercially avail-
able ELISA kits against MIF will be required
[3,12]. Although the SeroCP ELISA is comparable
to MIF, its level of reproducibility is not perfect,
and this fact should be considered when such a
kit is used in further epidemiological or diag-
nostic studies.
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ABSTRACT
Differences in inﬂammatory responses in human
adult whole blood to live pneumococcal serotypes
3, 7F, 9V and 23F were investigated. Using ﬂow
cytometry and ELISA, oxidative burst, expression
of activation markers CD11b ⁄CD18, and in-vitro
production of tumour necrosis factor-a, interleu-
kin-6 (IL-6) and interleukin-8 were measured.
There was no signiﬁcant difference between the
serotypes regarding any of the variables investi-
gated, although there was a trend towards higher
concentrations of IL-6 induced by serotypes 9V
and 23F. In the present experimental model, the
serotypes of Streptococcus pneumoniae shown pre-
viously to cause different degrees of inﬂammation
were found to cause a similar inﬂammatory
response in human whole blood.
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Clinical infection caused by Streptococcus pneumo-
niae is usually characterised by intense inﬂamma-
tion. Patients with bacteraemic pneumococcal
infection have high levels of C-reactive protein
and inﬂammatory cytokines, and patients with
pneumococcal meningitis have high concentra-
tions of pro-inﬂammatory cytokines in the
cerebrospinal ﬂuid [1–3]. It is believed that a
balanced inﬂammatory response is decisive for
the outcome of clinical infection. A minority of the
90 known serotypes of S. pneumoniae cause clinical
infection, but the occurrence of different serotypes
varies geographically and over time [4]. Different
serotypes of S. pneumoniae have been shown to
cause different degrees of inﬂammation in the
cerebrospinal ﬂuid of rabbits [5,6] and in cultures
of peripheral blood mononuclear cell cultures
[7,8]. In a previous study, clinical isolates of
different serotypes of S. pneumoniae were shown
to induce an oxidative burst and increased
expression of CD18 [9], and to induce pro-inﬂam-
matory cytokine production in whole blood [10].
In the present study, 12 different live clin-
ical isolates belonging to four different serotypes
of S. pneumoniae were studied with regard to
oxidative burst, CD11b ⁄CD18 expression and
pro-inﬂammatory cytokine production in adult
human whole blood. The aim of the study was to
investigate whether different live serotypes of
S. pneumoniae cause different degrees of inﬂam-
mation in human whole blood.
All isolates were from the blood of patients with
bacteraemic pneumococcal infection and were
serotyped at the Statens Serum Institut, Copenha-
gen, Denmark. Three strains of each of the four
serotypes 3, 7F, 9V and 23F were included in the
study. The strains were chosen after review of
previous studies in which serotypes 3 and 7F were
shown to cause mild inﬂammation, and serotypes
9V and 23F severe inﬂammation [5,6]. The strains
were kept frozen at ) 70 C, thawed and grown on
blood agar for 24 h to check purity, and then
cultured in fastidious anaerobic broth on a shaker
overnight at 37 C. After centrifugation at 2500 g
for 20 min, the bacteria were washed three times
and suspended in phosphate-buffered saline
solution (PBS) with Ca2+ (0.9 mmol ⁄L) and Mg2+
(0.5 mmol ⁄L) [11].
Whole blood was obtained from healthy donors
and collected in sterile tubes with sodium heparin
as an additive. The concentration of polymorpho-
nuclear leukocytes (PMNLs) was determined by
counting in a haemacytometer. In each experi-
ment, blood from three donors with the same
ABO and Rhesus blood group was used. When
isolated PMNLs were used, preparation was as
described previously [9,11].
Pooled serum [9,11] was used in experiments
with isolated PMNLs. The concentrations of
serotype-speciﬁc antibodies in the pooled serum
(expressed as a percentage of international stand-
ard 89-SF) were as follows: type 3, 85%; type 7F,
27%; type 9V, 25%; and type 23F, 22% (analysed
at the Statens Serum Institut). Heat-inactivation of
complement was done as described previously
[11]. Anti-pneumococcal antibodies were ab-
sorbed by incubating live S. pneumoniae serotype
3 with pooled serum. In short, one volume of
serum was mixed with one volume of bacterial
suspension and kept on ice for 60 min, after
which the pneumococci were centrifuged at
2500 g for 20 min. The absorbed serum was
ﬁltered through a 0.2-lm membrane ﬁlter. The
haemolytic activity of the absorbed sera did not
decrease by more than one two-fold titre step in
comparison with the complement titre of unab-
sorbed serum.
Flow cytometric analyses (ﬂuorescence activa-
ted cell sorting) were performed as described
previously [9]. In total, 5000 PMNLs were ana-
lysed ⁄ tube. The ﬂuorescence distribution was
displayed as a single histogram and the mean
ﬂuorescence channel was used for further calcu-
lations.
The PMNL oxidative burst response was deter-
mined using hydroethidine (Molecular Probes,
Leiden, The Netherlands), which becomes oxi-
dised to ethidium bromide when reacting with
oxidative metabolites within the PMNLs. Staining
of PMNLs with hydroethidine was performed as
described previously [9]. When expression of
CD18 and CD11b was studied, 10 lL of each
monoclonal antibody was added to the appropri-
ate tubes, and these were held for 60 min on ice.
The samples were then lysed and ﬁxed with 2 mL
of lysing solution (Becton Dickinson Immunocy-
tometric Systems, San Jose, CA, USA) at room
temperature for 10 min. After centrifugation
(400 g, 5 min) and removal of the supernatant,
the pellet was resuspended in 2 mL of PBS with
formaldehyde 1% v ⁄ v, followed by centrifugation
and resuspension in 0.4 mL of PBS with formal-
dehyde 1% v ⁄v. The tubes were then stored at
4 C for a maximum of 18 h until analysis.
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To study the effects of complement and anti-
body, the pneumococci (60 lL of an appropriate
concentration) were opsonised with 40 lL of
either pooled serum, heat-inactivated pooled
serum, or pooled serum absorbed with S. pneu-
moniae as described above. Opsonisation was
performed at 37 C for 15 min with agitation,
after which 20 lL was added to the isolated
PMNLs (at a ratio of ﬁve bacteria to one PMNL),
and ﬂuorescence activated cell sorting analysis
was performed as described above.
In-vitro experiments were also performed as
described previously [10]. Live S. pneumoniaewere
added to whole blood at a ratio of ﬁve bac-
teria ⁄monocyte. Whole blood (900 lL) was mixed
with 100 lL of bacterial suspension and incubated
for 4 h at 37 C in sterile 12 · 75 mm glass tubes.
The tubes were then put into icy water and
immediately centrifuged; the plasma was separ-
ated and stored at – 20 C for later analysis. Two
negative controls (PBS and whole blood) and four
positive controls (whole bloodplus either 100 pgor
1 ng of lipopolysacharide (Sigma-Aldrich, Dei-
senhofen, Germany)) were included. Cytokine
analysis was performed using commercially avail-
able tumour necrosis factor-a (TNF-a), interleukin-
6 (IL-6) and interkeukin-8 (IL-8) ELISA kits (R&D
Systems Europe, Abingdon, UK).
One-way ANOVA with a Bonferroni post test was
performed using GraphPad Prism version 3.00 for
Windows (GraphPad Software, San Diego, CA,
USA). The study was approved by the O¨rebro
County Council Ethics Committee.
All serotypes tested caused an increase in
oxidative burst and in expression of CD11b ⁄
CD18, but there was no signiﬁcant difference
between the four different serotypes. All sero-
types also induced production of IL-6, IL-8 and
TNF-a in whole blood. Production of IL-8 and
TNF-a showed no difference between the sero-
types, but there was a trend towards higher
concentrations of IL-6 caused by the serotypes 9V
and 23F, shown previously to cause severe
inﬂammation (p0.054) (Fig. 1). When isolated
neutrophils were used, the presence of comple-
ment was shown to be a prerequisite for an
oxidative burst. In the presence of complement,
even low levels of serotype-speciﬁc antibodies
were sufﬁcient for a respiratory burst to take
place. As shown in Fig. 2, a major reduction in
oxidative burst was seen when complement was
heat-inactivated. Absorption of serotype 3 anti-
bodies caused only a minor reduction in oxidative
burst from 781 to 603 (mean channel ﬂuorescence)
in the presence of normal complement activity.
When complement was heat-inactivated, the oxi-
dative burst response was reduced to 460.
The experimental conditions in the present
investigation were as similar as possible to the
intravascular situation in patients with bacterae-
mic pneumococcal infection. Previous studies of
the inﬂammatory response showed that serotypes
5 and 7F caused mild inﬂammation, and serotypes
6B, 14 and 23F severe inﬂammation, when the live
pneumococcal strains were injected directly into
the cisterna magna of rabbits [6]. It was suggested
that different serotypes of S. pneumoniae possess
individual virulence determinants causing dif-
ferent degrees of inﬂammation. Tauber et al. [5]
found three levels of inﬂammation using the same
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Fig. 1. The in-vitro production of IL-6 in human adult
whole blood after incubation for 4 h at 37 C with live
Streptococcus pneumoniae. Lo ¼ serotypes 3 and 7F; Hi ¼
serotypes 9V and 23F. Neg ¼ negative control, i.e., whole
blood incubated without S. pneumoniae; Pos 1 ng and
0.1 ng ¼ positive controls, i.e., whole blood incubated with
lipopolysaccharide 1 ng and 0.1 ng.
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Fig. 2. The neutrophil oxidative burst response to live
Streptococcus pneumoniae using human pooled serum with
known concentrations of complement and serotype-speci-
ﬁc immunoglobulin. The results are shown as a mean
percentage (+ SE) of the maximal oxidative response in
four experiments. PMNL, polymorphonuclear leukocytes;
SP, S. pneumoniae; Po, pooled serum; Pi, pooled serum, heat
inactivated.
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experimental model, with serotype 9 causing
severe, serotype 3 mild, and serotype 1 intermedi-
ate inﬂammation [5]. Clearly, the experimental
settingof the present studydiffers greatly from that
of the rabbit meningitis model, and it is also
possible that the difference in timing of measure-
ment may account for the differences in results.
When the relative importance of complement and
serotype-speciﬁc antibodies was evaluated, com-
plement was shown to be a prerequisite for an
oxidative burst, whereas even low levels of sero-
type-speciﬁc antibodymay be sufﬁcient to produce
an oxidative burst in neutrophils.
In conclusion, the inﬂammatory response in
human adult blood caused by the four different
serotypes of S. pneumoniaewas similar with regard
to oxidative burst, neutrophil expression of
CD11b ⁄CD18, and production of pro-inﬂamma-
tory cytokines such as TNF-a, IL-6 and IL-8,
although there was a trend towards higher con-
centrations of IL-6 induced by the serotypes shown
previously to induce severe inﬂammation (9V and
23F). Thus, the results of the present study do not
conﬁrm previous suggestions that different sero-
types of S. pneumoniae can cause different degrees
of inﬂammatory response in humans.
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ABSTRACT
Ninety-six Streptococcus pneumoniae strains isolated
between January 1989 and December 2000 from
usually sterile sites of children aged < 5 years of age
were included in the study. Resistance to penicillin
(38.6% intermediate, 10.4% high-level), cefotax-
ime (20.8%), tetracycline (41.7%), chlorampheni-
col (33.3%) and erythromycin (27.1%), as well as
serogroup ⁄ type, were related to age and pathol-
ogy. Strains from children aged < 2 years showed
the highest penicillin resistance rate. Resistance to
penicillin, tetracycline, chloramphenicol and ery-
thromycinwas themost commonpattern (18.8% of
strains). Most isolates (80.2%) belonged to sero-
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